SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2023 SESSION
SB 1084 Prescription of Schedule VI controlled substances; asynchronous interactions.
Introduced by: John J. Bell | all patrons ... notes | add to my profiles
SUMMARY AS INTRODUCED:
Prescription of Schedule VI controlled substances; asynchronous interactions; report. Allows practitioners to establish a bona fide practitioner-patient relationship through asynchronous interaction for the purpose of prescribing Schedule VI controlled substances if the patient chooses not to use insurance for the encounter and if such prescribing complies with federal requirements for the practice of telemedicine. The bill directs the Board of Pharmacy to conduct a review of Schedule VI controlled substances and report to the Chairmen of the Senate Committee on Education and Health and the House Committee on Health, Welfare and Institutions by December 31, 2023, any Schedule VI substances that the General Assembly may want to consider rescheduling due to potential risk of abuse by a patient if prescribed in accordance with the standard of care for asynchronous telemedicine interactions.
FULL TEXT
HISTORY
- 01/09/23 Senate: Prefiled and ordered printed; offered 01/11/23 23104083D
- 01/09/23 Senate: Referred to Committee on Education and Health
- 01/11/23 Senate: Assigned Education sub: Health Professions
- 01/26/23 Senate: Stricken at request of patron in Education and Health (14-Y 0-N)